ERAS
Erasca Inc.
$11.50
+$0.26(+2.31%)
39
Overall
40
Value
45
Tech
34
Quality
Market Cap
$3.21B
Volume
3.17M
52W Range
$1.06 - $24.28
Target Price
$19.90
Latest News for ERAS
Analysts Offer Insights on Healthcare Companies: Immunovant (IMVT) and Erasca (ERAS)
Christine Brown•a day ago•May 25, 2026
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immunovant (IMVT) and Erasca (ERAS) with bullish sen......
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Erasca (ERAS), Liquidia Technologies (LQDA) and DocGo (DCGO)
Catie Powers•15 days ago•May 12, 2026
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Erasca (ERAS), Liquidia Technologies (LQDA) and Do......
Erasca Reports Encouraging Phase 1 Data for ERAS-0015
TipRanks Auto-Generated Newsdesk•a month ago•Apr 27, 2026
An announcement from Erasca ( ($ERAS) ) is now available. On April 27, 2026, Erasca reported positive preliminary Phase 1 dose escalation results f......
News data is sourced from MarketXLS API and updated regularly.
Showing 3 of 3 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ERAS | $11.50 | +2.3% | 3.17M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |